S&P Pharmaceuticals SPDR (XPH)
$53.69 0.30 (0.56%)
19:59 EST XPH Stock Quote Delayed 30 Minutes
Previous Close -
Market Cap 3.03M
PE Ratio -
Volume (Avg. Vol.) 23,500
Day's Range 53.23 - 53.99
52-Week Range 30.30 - 54.60
Dividend & Yield 0.24 (0.45%)
XPH Stock Predictions, Articles, and S&P Pharmaceuticals SPDR News
- From InvestorPlace
- From the Web
Pharmaceutical stocks help make the world go round. Without them, common ailments would plague our lives. With them, we can solve Covid-19.
This week I want to take a bullish position in the underperforming pharmaceutical sector with Apellis Pharmaceuticals, Inc. (NASDAQ:APLS).
Traders need to be selective with their options, and Johnson & Johnson (NYSE:JNJ) has proven itself resilient.
While the rest of the market continues upward, the healthcare sector -- and healthcare ETFs -- continue to struggle.
Some of the best healthcare ETFs to buy are more "traditional", while others focus on very specific areas of the industry. These seven healthcare ETFs should deliver for investors over the remainder of 2018.
You cannot make this stuff up. The median stock in the S&P 500 has never been more overvalued on these key metrics. Now's the time for caution...